- Deplin®
- is an anti-depressant augmentation with 7.5mg of L-methylfolate. L-methylfolate is able to cross the blood brain barrier and aid in the development of serotonin, norepinephrine and dopamine's neurotransmitters
- Néevo®
- is a prescription medical food for the prenatal dietary management of preconception and pregnant mothers with specific emphasis for older OB patients, high-risk pregnancies and those patients with the MTHFR folate polymorphism. Néevo® includes all of the traditionally prescribed prenatal vitamins and minerals as recommended by ACOG.
Pain Relief
- Panlor® SS & Panlor® DC
- - indicated for the analgesic relief of moderate to moderately severe pain. Each dose contains an effective triad formula of dihydrocodeine, acetaminophen and caffeine. [Schedule CIII]
Allergy Relief
- Palgic®
- - indicated for the effective relief of allergy symptoms caused by seasonal and perennial allergic rhinitis.
Medical Foods
- Cerefolin®NAC
- - indicated for the distinct nutritional requirements of individuals under a physician's treatment for neurovascular oxidative stress and/or hyperhomocysteinemia; with particular emphasis for those individuals diagnosed with or at risk for mild to moderate cognitive impairment, vascular dementia, Alzheimer's disease and/or recurrent or ischemic stroke.
- Metanx®
- - for the dietary management of endothelial dysfunction and/or hyperhomocysteinemia. The active, natural occurring B-vitamins in Metanx® are directly associated with metabolizing homocysteine, a risk factor for vascular disease, and improving the overall health of the blood vessels.
- Diatx®Zn
- - for the distinct nutritional requirements of patients under a physician's treatment for hyperhomocysteinemia; with particular emphasis for those individuals diagnosed with chronic kidney disease, end stage renal disease, or dialysis.
- Foltx®
- - for the distinct nutritional requirements of individuals under a physician's treatment for hyperhomocysteinemia, homocystinuria, or nutrient malabsorbtion; with particular emphasis for individuals with or at risk for: cardiovascular disease, peripheral vascular disease, arteriosclerotic vascular disease, and vitamin B12 deficiency.
